Navigation Links
Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial
Date:12/8/2010

SUNRISE, Fla., Dec. 8, 2010 /PRNewswire-FirstCall/ -- Bioheart, Inc. (OTC Bulletin Board: BHRT) announced today that at the American Heart Association Annual Meeting, it finalized the formation of a working group. The group's focus is to advance a BRIDGE TO RECOVERY clinical trial, combining a left ventricle assist device (LVAD) and Bioheart's MyoCell adult muscle stem cell composition and Bioheart's MyoCath needle tipped catheter delivery system.   Initial participants in developing this proposed protocol design include:Dr. Frank Pagani, University of MichiganDr. Warren Sherman, Columbia UniversityDr. Ernst Schwarz, Ceders Sinai UCLADr. Nabil Dib, University of California San Diego and Mercy Gilbert Hospital PhoenixDr. Carl Pepine, University of Florida Shands HospitalDr. Doris Taylor, University of MinnesotaThe expected study design pending potential modification will include 3 treatment arms: Group 1 - Patients receive MyoCell SDF-1 single dose via MyoCath catheter delivery after LVAD placement.Group 2 - Patients receive MyoCell in multiple injection sessions over 6 months via MyoCath catheter delivery following LVAD placement.Group 3 - Patients receive LVAD only. The end points in the trial will include exercise capacity, functional improvements and success in weaning off the LVAD."At the AHA meeting, improvements in survival of heart failure patients were reported from trials with battery powered pacers and mechanical left ventricle assist heart pumps.  These devices help patients cope with their failing heart, but do little to repair damaged scar tissue in the heart, which is often the primary source of heart failure.  The MyoCell composition from Bioheart has demonstrated an ability to grow new contractile muscle in scar tissue and thus, may actually address the underlying problem.  Supporting the patient with an LVAD temporarily during the time period
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
2. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
3. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
4. Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
5. Leading Experts Endorse Biohearts Muscle Stem Cell MyoCell Therapy
6. Biohearts MyoCell Recognized as one of the Breakthrough Developments of 2010
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... MOUNTAIN VIEW, Calif. , Sept. 30, 2014 /PRNewswire/ ... today, which integrates with HealthKit in iOS 8 and ... with their doctors. The app harnesses native iOS technologies ... patients to maintain a robust connection with their doctors ... wearable health devices and the data they collect is ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 ... growth stage. Both established medical-device providers as well as ... Eastern European region, while simultaneously looking at ways to ... this sector. Using distributors is one of the effective ... the medical devices distribution market in Eastern European and ...
(Date:9/30/2014)... The report based on "Nutraceutical ... Growth and Forecast, 2007 - 2017," elaborated by Transparency ... billion in 2012 and is further expected to reach ... of 7.3% from 2012 to 2017. Nutraceutical ... especially to prevent chronic diseases that may occur to ...
Breaking Medicine Technology:HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Medical Technologies Distributor Profiles in Eastern Europe 2Medical Technologies Distributor Profiles in Eastern Europe 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4
(Date:9/30/2014)... is no stranger to the children of Tanzania. What ... to clinical services, including reliable diagnosis and evidence-based treatments. ... for use in Swahili, a major language of the ... Brown University and the University of Georgia (UGA) describe ... two sites in the country and found to be ...
(Date:9/30/2014)... NJ (PRWEB) September 30, 2014 ... and wellness, is opening another new medical specialty practice ... IMA Cardiology will be located within the ... Ziad Abbud and Dr. Isaac Tawfik of American Heart ... N.J. The new practice will offer Integrated Medicine Alliance ...
(Date:9/30/2014)... Las Vegas, NV (PRWEB) September 30, 2014 ... released by Blue Star Nutraceuticals designed to help maximize ... ingredients that optimizes the body’s absorption of glucose has ... review. , “The main purpose behind Glycodrive is ... that builds lean muscle,” reports Michaels. “Carbs are essential ...
(Date:9/30/2014)... VisitandCare.com reports that revenue for ... more than 79 percent in 2014, marking five straight ... total revenue tripled for its entirety of partnered medical ... has allowed them to partner with plastic surgery ... and privacy — with state-of-the-art surgical atmospheres aimed to ...
(Date:9/30/2014)... A group of Americans is headed to ... that, left unchecked, could create a catastrophic, global pandemic. No, ... Africa. John Rogers, the Executive Director the Eugene Bell Foundation ... a disease most think mankind conquered long ago: tuberculosis. , ... is on the comeback in several countries - what’s especially ...
Breaking Medicine News(10 mins):Health News:New diagnostic approach for autism in Tanzania 2Health News:New diagnostic approach for autism in Tanzania 3Health News:New diagnostic approach for autism in Tanzania 4Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:US Delegation Heads to North Korea to Combat Tuberculosis Epidemic 2
... most common vascular complication after living donor liver ... devastating consequences. Surgical techniques are suggested to an ... surgical techniques, arterial reconstruction in LDLT has a ... techniques, the reconstruction of HA was accomplished in ...
... Thursday 17 June 2010: Smoking cigarettes is a significant ... have a negative impact on the effectiveness of anti-tumour ... treatments, according to results of two studies presented today ... League Against Rheumatism in Rome, Italy. A further study ...
... in shape may bolster the metabolic profiles of college ... fat percentages. In an epidemiological study, researchers at the ... University found an association between physical fitness, body fat ... to cardiovascular disease and Type 2 diabetes. ...
... ... , ... 17, 2010 -- SleepBetter.org, the web,s premier source for news, tips, and information on how ... to help their children settle down for a good night,s sleep. The Bedtime Stories ...
... Enhance your ... , ... 17, 2010 -- Whether it’s a backyard barbecue, family reunion, birthday party, picnic, July 4 ... sold at Walmart in the candy aisle, adds a new and exciting touch to your ...
... costlier drugs increased after new rules took effect, study ... in Medicare payments to doctors who administer outpatient chemotherapy ... among Medicare recipients, finds a new study. , "This ... would expect, but economists often encounter this sort of ...
Cached Medicine News:Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 3Health News:Physical fitness may help reduce chronic disease risk in college students 2Health News:Sleep Tips Web Site SleepBetter.org Expands The Bedtime Stories Project 2Health News:Sleep Tips Web Site SleepBetter.org Expands The Bedtime Stories Project 3Health News:Top Off Your Favorite Summer Treat with NOT JUST CEREAL™ 2Health News:Top Off Your Favorite Summer Treat with NOT JUST CEREAL™ 3Health News:Medicare Cuts May Have Led Docs to Prescribe More Chemo 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: